Company name PharMerica Corporation
Stock symbol PMC
Status Under Investigation

NEW YORK, August 3, 2017 – Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of PharMerica Corporation (NYSE: PMC) stockholders concerning the proposed acquisition of the company by KKR & Co. L.P. (NYSE: KKR) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA).

The investigation concerns whether PharMerica Corporation’s board of directors failed to adequately shop the Company and obtain the best possible value for PharMerica stockholders before entering into a definitive merger agreement with KKR and Walgreens Boots Alliance.  Under the terms of the agreement, PharMerica Corporation stockholders will receive $29.25 in cash for each share of PharMerica common stock upon closing of the proposed transaction.

If you own PharMerica shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

First name*

Last name*

City, state, ZIP code*

Email address*

Daytime phone*

Evening phone

Purchase Date*

No. of Shares*

Purchase Price*

Purchase Date

No. of Shares

Purchase Price

Call to provide more information: Tel: (212) 308-5858

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.